Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Tennessee Medical Policy Updates – December 2024
Stay ahead in medical policy monitoring and tracking with personalized reports and a real-time dashboard tailored to specific products, procedures, or codes. For those seeking a more impactful solution than Policy Reporter, our platform delivers comprehensive data analytic tools, user-friendly dashboard and collaboration features, client-focused solutions, and real-time email alerts.
Schedule a demo to see how our focused reports save time and provide actionable insights for your reimbursement and commercialization efforts.
Click here to view the Blue Cross Blue Shield BCBS Tennessee Medical Policy Updates »
December 2024 BCBS Tennessee Medical Policy Updates:
- Afamitresgene Autoleucel (Tecelra®)
- Aflibercept
- Alemtuzumab
- Amivantamab-vmjw (Rybrevant™)
- Axicabtagene Ciloleucel
- Belinostat
- Benralizumab
- Bevacizumab for the Treatment of Neoplastic Disease
- Casimersen (Amondys 45™)
- Cerliponase Alfa
- Durvalumab
- Epcoritamab-bysp (Epkinly™)
- Epoprostenol
- Eteplirsen
- First-Trimester Detection of Down Syndrome Using Fetal Ultrasound Markers Combined with Maternal Serum Assessment
- Golodirsen
- Hematopoietic Stem-Cell Transplantation for Malignant Astrocytomas and Gliomas
- Ipilimumab
- KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy
- Lisocabtagene Maraleucel (Breyanzi®)
- Mepolizumab
- Mitomycin Gel
- Nadofaragene firadenovec-vncg (Adstiladrin®)
- Navigated Transcranial Magnetic Stimulation
- Nivolumab
- Omalizumab
- Powered Exoskeleton for Ambulation in Individuals with Lower-Limb Disabilities
- Pralatrexate
- Pulmonary Arterial Hypertension Agents
- Reslizumab
- Retinal Telescreening for Diabetic Retinopathy
- Risankizumab-rzaa (Skyrizi®)
- Rituximab and Hyaluronidase Human Injection
- Rituximab Products (Rituxan®, Rituximab-abbs [Truxima®],Rituximab-arrx [Riabni™] and Rituximab-pvvr [Ruxience®]) (Non-Oncology Indications)
- Sotatercept-csrk (WinrevairI™)
- Spinal Cord Stimulation / Peripheral Subcutaneous Field Stimulation for the Treatment of Pain
- Temozolomide for Injection
- Temsirolimus
- Tezepelumab-ekko (Tezspire™)
- Tisagenlecleucel
- Toripalimab-tpzi (Loqtorzi)
- Trastuzumab
- Ustekinumab
- Viltolarsen
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
